Detalhe da pesquisa
1.
Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.
BMC Med
; 21(1): 300, 2023 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37559142
2.
Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate.
J Am Acad Dermatol
; 86(3): 688-690, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33684488
3.
The Survival Benefit of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in the Management of Breast Cancer.
Cancer Biother Radiopharm
; 2024 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38512710
4.
A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes.
Sci Rep
; 14(1): 9596, 2024 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38671007
5.
Bioinformatic analysis reveals an association between Metadherin with breast cancer prognosis and tumor immune infiltration.
Sci Rep
; 14(1): 1949, 2024 01 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38253625
6.
Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3ß signaling pathway.
Chem Biol Drug Des
; 103(1): e14416, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38093418
7.
Role of glutaminyl-peptide cyclotransferase in breast cancer doxorubicin sensitivity.
Cancer Biol Ther
; 25(1): 2321767, 2024 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38417050
8.
Clinical study of disseminated tumor cells in bone marrow of patients with gastric cancer.
Hepatogastroenterology
; 60(122): 273-6, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-22951525
9.
Exploring risk factors for totally implantable venous access devices (TIVADs)-related thrombotic occlusion in the off-treatment period.
Sci Rep
; 13(1): 10767, 2023 07 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37402879
10.
Calcium dobesilate prevents PLD-induced hand-foot syndrome by alleviating capillary endothelial tight junction injury via the HA/CD44 pathway.
Am J Cancer Res
; 13(7): 3234-3245, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37559988
11.
Monitoring circulating platelet activity to predict cancer-associated thrombosis.
Cell Rep Methods
; 3(7): 100513, 2023 07 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37533637
12.
Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer.
Cancer Res
; 83(17): 2924-2937, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37326467
13.
Research on shifting process control of automatic transmission.
Sci Rep
; 12(1): 13054, 2022 07 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35906290
14.
miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin.
Oncol Lett
; 23(5): 162, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35399330
15.
Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study.
Front Oncol
; 12: 909426, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35875123
16.
Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus.
Sci Rep
; 11(1): 10034, 2021 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33976288
17.
[Proteomic identification and comparison of differentiation-related proteins in gastric carcinoma cell lines].
Zhonghua Zhong Liu Za Zhi
; 32(3): 179-84, 2010 Mar.
Artigo
Chinês
| MEDLINE | ID: mdl-20450584
18.
[Relationship of cyclooxygenase-2 and multidrug resistance associated factors to chemosensitivities in gastrointestinal carcinomas].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 41(1): 128-31, 2010 Jan.
Artigo
Chinês
| MEDLINE | ID: mdl-20369487
19.
A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer.
Oncol Res Treat
; 42(5): 269-274, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30943501
20.
Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab.
Medicine (Baltimore)
; 98(36): e16937, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31490377